Literature DB >> 16820825

Point of care testing for C-reactive protein - a new path for Australian GPs?

Hasse Melbye1, Nigel Stocks.   

Abstract

BACKGROUND: New approaches are needed to reduce antibiotic usage in respiratory tract infections in general practice without compromising patient safety. Point of care tests for C-reactive protein (CRP) are now being used for this purpose in some European countries.
OBJECTIVE: Current knowledge about the CRP response in respiratory tract infections is presented, as well as the usefulness of applying the test when sinusitis and pneumonia may be suspected. DISCUSSION: A promising ability of the test in ruling in or out severe infection has been demonstrated in clinical studies. There are still controversies about the use of the CRP test in respiratory tract infections, however clinical research supports its use for some conditions, and therefore introduction into Australian general practice should be considered. Further evaluation of its utility is needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820825

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  6 in total

1.  A pilot study of the use of near-patient C-Reactive Protein testing in the treatment of adult respiratory tract infections in one Irish general practice.

Authors:  Kim E Kavanagh; Eamonn O'Shea; Rita Halloran; Peter Cantillon; Andrew W Murphy
Journal:  BMC Fam Pract       Date:  2011-08-31       Impact factor: 2.497

2.  Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department.

Authors:  Marilena Minieri; Vito N Di Lecce; Maria Stella Lia; Massimo Maurici; Francesca Leonardis; Susanna Longo; Luca Colangeli; Carla Paganelli; Stefania Levantesi; Alessandro Terrinoni; Vincenzo Malagnino; Domenico J Brunetti; Alfredo Giovannelli; Massimo Pieri; Marco Ciotti; Cartesio D'Agostini; Mariachiara Gabriele; Sergio Bernardini; Jacopo M Legramante
Journal:  Diagnostics (Basel)       Date:  2022-08-15

3.  Evaluation of a potential prognostic parameter for the inflammatory status in COVID-19 patients: The inflammatory protein ratio.

Authors:  Francescopaolo Antonucci; Domenico Di Carlo; Michele Falcone
Journal:  Electrophoresis       Date:  2022-05-19       Impact factor: 3.595

Review 4.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

5.  Usefulness of C-reactive protein testing in acute cough/respiratory tract infection: an open cluster-randomized clinical trial with C-reactive protein testing in the intervention group.

Authors:  Elena Andreeva; Hasse Melbye
Journal:  BMC Fam Pract       Date:  2014-05-02       Impact factor: 2.497

6.  What a difference a CRP makes. A prospective observational study on how point-of-care C-reactive protein testing influences antibiotic prescription for respiratory tract infections in Swedish primary health care.

Authors:  Johan Lindström; Lena Nordeman; Bertil Hagström
Journal:  Scand J Prim Health Care       Date:  2015-12-07       Impact factor: 2.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.